| Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors (NCT07769242) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-09-01 |
| The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients (NCT07739160) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-08-15 |
| A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors (NCT07404553) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-04-30 |
| A Study of SHR-1918 In Participants With Hypertriglyceridemia (NCT07349615) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-04-01 |
| A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia (NCT07230730) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-01-13 |
| A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses (NCT07280936) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-01-05 |
| A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure (NCT07230145) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-11-01 |
| Safety, Tolerability and Pharmacokinetic Study of HRS-8829 (NCT07083362) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-08-06 |
| Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia (NCT07133815) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-08-01 |
| A Single Ascending Dose of HRS-4029 in Healthy Subjects (NCT06905314) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-04-01 |
| A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT06825416) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-03-16 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia (NCT06723652) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-02-13 |
| The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction (NCT06732648) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-02-07 |
| Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia (NCT06471218) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2024-07-02 |
| Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation (NCT06280768) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2024-04-10 |
| A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery (NCT06220123) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2024-02-16 |
| Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia (NCT06009393) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-12-22 |
| Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic (NCT06109831) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-11-24 |
| SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT05752461) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-04-12 |
| A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction (NCT05690711) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-04-07 |
| Safety and Tolerability of SHR-1918 in Healthy Subjects (NCT05432544) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-06-27 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects (NCT05369767) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-05-24 |
| Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects (NCT05330208) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2022-05-18 |